ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc (ACAD)

16,77
-0,41
(-2,39%)
Geschlossen 13 März 9:00PM
16,8001
0,0301
(0,18%)
Nach Börsenschluss: 12:00AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
16,8001
Gebot
16,70
Fragen
17,70
Volumen
1.632.262
16,75 Tagesbereich 17,3999
14,15 52-Wochen-Bereich 20,68
Marktkapitalisierung
Handelsende
17,18
Handelsbeginn
17,23
Letzte Trade
2
@
17.6999
Letzter Handelszeitpunkt
Finanzvolumen
US$ 27.974.300
VWAP
17,1384
Durchschnittliches Volumen (3 Mio.)
2.628.013
Ausgegebene Aktien
166.391.891
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-45,48
Gewinn pro Aktie (EPS)
-0,37
Erlöse
726,44M
Nettogewinn
-61,29M

Über Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks t... Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Acadia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACAD. The last closing price for Acadia Pharmaceuticals was US$17,18. Over the last year, Acadia Pharmaceuticals shares have traded in a share price range of US$ 14,15 to US$ 20,68.

Acadia Pharmaceuticals currently has 166.391.891 shares in issue. The market capitalisation of Acadia Pharmaceuticals is US$2,86 billion. Acadia Pharmaceuticals has a price to earnings ratio (PE ratio) of -45.48.

Option-Flow Acadia Pharmaceuticals (ACAD)

Gesamtfluss

Bullisch

Nettoprämie

40k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

ACAD Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.5999-8.6951086956518.418.5216.75157195117.51455604CS
4-1.5349-8.3714207799318.33520.6816.75188000818.98637838CS
12-0.6849-3.9170717758117.48520.6816.27262801318.27990466CS
260.86015.3958594730215.9420.6814.15195007617.41805124CS
52-2.6899-13.801436634219.4920.6814.15186005517.11618201CS
156-6.2199-27.019548218923.0233.9912.24176048819.70917842CS
260-17.4599-50.962930531234.2658.7212.24167001724.32954898CS

ACAD - Frequently Asked Questions (FAQ)

What is the current Acadia Pharmaceuticals share price?
The current share price of Acadia Pharmaceuticals is US$ 16,8001
How many Acadia Pharmaceuticals shares are in issue?
Acadia Pharmaceuticals has 166.391.891 shares in issue
What is the market cap of Acadia Pharmaceuticals?
The market capitalisation of Acadia Pharmaceuticals is USD 2,86B
What is the 1 year trading range for Acadia Pharmaceuticals share price?
Acadia Pharmaceuticals has traded in the range of US$ 14,15 to US$ 20,68 during the past year
What is the PE ratio of Acadia Pharmaceuticals?
The price to earnings ratio of Acadia Pharmaceuticals is -45,48
What is the cash to sales ratio of Acadia Pharmaceuticals?
The cash to sales ratio of Acadia Pharmaceuticals is 3,84
What is the reporting currency for Acadia Pharmaceuticals?
Acadia Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Acadia Pharmaceuticals?
The latest annual turnover of Acadia Pharmaceuticals is USD 726,44M
What is the latest annual profit for Acadia Pharmaceuticals?
The latest annual profit of Acadia Pharmaceuticals is USD -61,29M
What is the registered address of Acadia Pharmaceuticals?
The registered address for Acadia Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Acadia Pharmaceuticals website address?
The website address for Acadia Pharmaceuticals is www.acadia-pharm.com
Which industry sector does Acadia Pharmaceuticals operate in?
Acadia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CRVOCervoMed Inc
US$ 6,15
(160,59%)
158,89M
ZENAZenaTech Inc
US$ 4,5505
(61,94%)
6,89M
OPRXOptimizeRx Corporation
US$ 6,265
(51,33%)
16,41M
SSPEW Scripps Company
US$ 2,05
(43,36%)
18,27M
GRPNGroupon Inc
US$ 13,9807
(43,10%)
11,17M
HITHealth In Tech Inc
US$ 1,32
(-82,31%)
16,73M
SPHLSpringview Holdings Ltd
US$ 1,24
(-79,33%)
10,7M
APDNApplied DNA Sciences Inc
US$ 0,0619
(-57,89%)
35,11M
ZYXIZynex Inc
US$ 3,39
(-51,57%)
3,82M
HEPAHepion Pharmaceuticals Inc
US$ 0,0488
(-41,90%)
79,16M
STISolidion Technology Inc
US$ 0,174899
(38,70%)
584,7M
NVDANVIDIA Corporation
US$ 115,74
(6,42%)
323,86M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,1432
(15,59%)
222,8M
VSTEVast Renewable Ltd
US$ 0,6182
(23,66%)
193,78M
CRVOCervoMed Inc
US$ 6,15
(160,59%)
158,89M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen